The global thrombosis drugs market size was estimated at USD 26.11 billion in 2024 and is projected to reach USD 52.30 billion by 2033, growing at a CAGR of 8.03% from 2025 to 2033. The growth of this market is primarily driven by the high prevalence of cardiovascular diseases (CVDs... Read More »
November 2025The global benign positional vertigo market size was estimated at USD 1.84 billion in 2024 and is projected to reach USD 2.73 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The benign positional vertigo industry is driven by the growing prevalence of vestibular disorders, ... Read More »
November 2025The global cancer cachexia market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.90 billion by 2033, growing at a CAGR of 4.86% from 2025 to 2033. The rising cancer incidence and more patients with cachexia, and growing recognition of cachexia’s clin... Read More »
November 2025The global pulmonary arterial hypertension market size was estimated at USD 8.02 billion in 2024 and is projected to reach USD 13.34 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market growth is majorly attributed to increasing support from government & healthcar... Read More »
November 2025The global pericardium diseases market size was estimated at USD 2.96 billion in 2024 and is projected to reach USD 5.06 billion by 2033, growing at a CAGR of 6.14% from 2025 to 2033. The growth is driven by the prevalence of cardiovascular conditions, aging populations, and improved dia... Read More »
November 2025The global biosimilars market size was estimated at USD 33.92 million in 2024 and is projected to reach USD 151.58 million by 2033, growing at a CAGR of 18.27% from 2025 to 2033. The cost-effectiveness of biosimilar drugs and the prevalence of chronic disorders globally are major factors... Read More »
October 2025The global thyroid support supplements market size was estimated at USD 1.87 billion in 2024 and is projected to reach USD 4.08 billion by 2033, growing at a CAGR of 9.29% from 2025 to 2033. Increasingly, consumers are looking for natural and herbal supplements with ingredients such as i... Read More »
October 2025The global acute pancreatitis market size was estimated at USD 3.37 billion in 2024 and is projected to reach USD 5.60 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. The market is largely driven by rising awareness of pancreatic health, an increasing prevalence of lifestyl... Read More »
October 2025The global hemorrhoids treatment market size was estimated at USD 762.99 million in 2024 and is projected to reach USD 1,465.28 million by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The increasing prevalence of hemorrhoidal disorders is driving market growth, influenced by sedentary lifestyles, poor diets, r... Read More »
October 2025The global antithrombin market size was estimated at USD 658.4 million in 2024 and is projected to reach USD 997.2 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The rising prevalence of coagulation disorders such as deep vein thrombosis, pulmonary embolism, and hereditary... Read More »
October 2025The global ankylosing spondylitis market size was estimated at USD 6.29 billion in 2024 and is projected to reach USD 11.08 billion by 2033, growing at a CAGR of 6.4% from 2025 to 2033. The market is growing due to the rising prevalence of inflammatory diseases and greater diagnostic awa... Read More »
October 2025The global hyperkalemia drugs market size was estimated at USD 1.23 billion in 2024 and is projected to reach USD 3.87 billion by 2033, growing at a CAGR of 13.8% from 2025 to 2033. The market growth is primarily driven by an aging population, increasing prevalence of chronic diseases li... Read More »
October 2025The global sinusitis drugs market size was estimated at USD 2.91 billion in 2024 and is projected to reach USD 4.49 billion by 2033, growing at a CAGR of 4.9% from 2025 to 2033. The industry is driven by the high prevalence of sinus-related conditions worldwide. Sinusitis, including acut... Read More »
October 2025The Canada endometriosis treatment market size was estimated at USD 53.58 million in 2024 and is projected to reach USD 156.71 million by 2033, growing at a CAGR of 13.26% from 2025 to 2033. The growth is driven by increasing awareness, advancements in treatment options, improved healthc... Read More »
October 2025The global hematuria treatment market size was estimated at USD 1,087.3 million in 2024 and is projected to reach USD 1,426.9 million by 2033, growing at a CAGR of 3.1% from 2025 to 2033. The market is driven by urological care and sustained by the growing prevalence of recurrent urinary... Read More »
October 2025The U.S. asthma therapeutics market size was estimated at USD 13.00 billion in 2024 and is projected to reach USD 19.20 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The rising number of asthma patients in the U.S. has led to a growing demand for effective therapies, incl... Read More »
October 2025The global oral mucositis market size was estimated at USD 1.50 billion in 2024 and is projected to reach USD 2.85 billion by 2033, growing at a CAGR of 7.35% from 2025 to 2033. The rising clinical burden of Oral Mucositis (OM) is one of the major factors driving the market growth for or... Read More »
October 2025The global respiratory health supplements market size was estimated at USD 8.11 billion in 2024 and is projected to reach USD 15.57 billion by 2033, expanding at a CAGR of 7.7% from 2025 to 2033. The market expansion is driven by rising consumer awareness of preventive healthcare, increa... Read More »
October 2025The global allergy diagnostics and therapeutics market size was estimated at USD 34.42 billion in 2024 and is projected to reach USD 78.00 billion by 2033, growing at a CAGR of 9.7% from 2025 to 2033. Some of the major factors driving the market are rising incidence of allergies, advance... Read More »
October 2025The global glioblastoma multiforme treatment market size was estimated at USD 3.72 billion in 2024 and is projected to reach USD 7.87 billion by 2033, growing at a CAGR of 8.68% from 2025 to 2033. The rising prevalence of Glioblastoma Multiforme (GBM) and its significant clinical burden ... Read More »
October 2025